Nonalcoholic fatty liver in children and adolescents: An overview

Journal of Adolescent Health

Volumn 51, Issue 4, 2012, Pages 305-312

  Della Corte, Claudia ^a   Alisi, Anna ^a   Saccari, Alessia ^a   De Vito, Rita ^a   Vania, Andrea ^b   Nobili, Valerio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Children; NAFLD; NASH; Obesity

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; ASCORBIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INFLIXIMAB; METFORMIN; PENTOXIFYLLINE; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADOLESCENT DISEASE; CHILDHOOD DISEASE; GOLD STANDARD; HUMAN; INDUSTRIALIZATION; LIVER BIOPSY; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; WEIGHT REDUCTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FATTY LIVER; FEMALE; HUMANS; MALE; RISK FACTORS; YOUNG ADULT;

EID: 84866740550     PISSN: 1054139X     EISSN: 18791972     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2012.01.010     Document Type: Review

References (100)

1. J. Ludwig, T.R. Viggiano, D.B. McGill, B.J. Oh Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 1980 434 438
2. N.J. Barshop, C.B. Sirlin, J.B. Schwimmer, J.E. Lavine Review article: Epidemiology, pathogenesis and potential treatments of pediatric non-alcoholic fatty liver disease Aliment Pharmacol Ther 28 2008 13 24
3. M. Moya An update in prevention and treatment of pediatric obesity World J Pediatr 4 2008 173 185
4. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
5. J.P. Ong, Z.M. Younossi Epidemiology and natural history of NAFLD and NASH Clin Liver Dis 11 2007 1 16
6. J.B. Schwimmer, P.E. Pardee, J.E. Lavine Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease Circulation 118 2008 277 283
7. G. Marchesini, E. Bugianesi, G. Forlani Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 2003 917 923
8. G. Perseghin The role of non-alcoholic fatty liver disease in cardiovascular disease Dig Dis 28 2010 210 213
9. G. Targher, L. Bertolini, R. Padovani Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes J Hepatol 53 2010 713 718
10. R.S. Strauss, S.E. Barlow, W.H. Dietz Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents J Pediatr 136 2000 727 733
11. H.S. Park, J.H. Han, K.M. Choi, S.M. Kim Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents Am J Clin Nutr 82 2005 1046 1051
12. R.E. Quirós-Tejeira, C.A. Rivera, T.T. Ziba Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or = 95th percentile J Pediatr Gastroenterol Nutr 44 2007 228 236
13. J.B. Schwimmer, R. Deutsch, T. Kahen Prevalence of fatty liver in children and adolescents Pediatrics 118 2006 1388 1393
14. M. Manco, G. Bedogni, M. Marcellini Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis Gut 57 2008 1283 1287
15. J.B. Schwimmer, C. Behling, R. Newbury Histopathology of pediatric nonalcoholic fatty liver disease Hepatology 42 2005 641 649
16. E. Malecka-Tendera, A. Mazur Childhood obesity: A pandemic of the twenty-first century Int J Obes (Lond) 30 Suppl 2 2006 S1 S3
17. I. Lissau Overweight and obesity epidemic among children Answer from European countries Int J Obes Relat Metab Disord 28 Suppl 3 2004 S10 S15
18. E.A. Roberts Pediatric non-alcoholic fatty liver disease (NAFLD): A "growing" problem? J Hepatol 46 2007 1133 1142
19. M.D. Deboer Ethnicity, obesity and the metabolic syndrome: Implications on assessing risk and targeting intervention Expert Rev Endocrinol Metab 6 2011 279 289
20. J.B. Schwimmer, N. McGreal, R. Deutsch Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents Pediatrics 115 2005 e561 e565
21. Y. Gutierrez-Grobe, G. Ponciano-Rodríguez, M.H. Ramos Prevalence of nonalcoholic fatty liver disease in premenopausal, postmenopausal and polycystic ovary syndrome women The role of estrogens Ann Hepatol 9 2010 402 409
22. J.B. Schwimmer, M.A. Celedon, J.E. Lavine Heritability of nonalcoholic fatty liver disease Gastroenterology 136 2009 1585 1592
23. A.E. Feldstein Novel insights into the pathophysiology of nonalcoholic fatty liver disease Semin Liver Dis 30 2010 391 401
24. S. Romeo, J. Kozlitina, C. Xing Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
25. L. Valenti, A. Alisi, E. Galmozzi I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease Hepatology 52 2010 1274 1280
26. D.G. Tiniakos, M.B. Vos, E.M. Brunt Non-alcoholic fatty liver disease: Pathology and pathogenesis Annu Rev Pathol 5 2010 145 171
27. E.M. Brunt Pathology of nonalcoholic fatty liver disease Nat Rev Gastroenterol Hepatol 7 2010 195 203
28. P. Tessari, A. Coracina, A. Cosma, A. Tiengo Hepatic lipid metabolism and non-alcoholic fatty liver disease Nutr Metab Cardiovasc Dis 19 2009 291 302
29. H. Tilg, A.R. Moschen Insulin resistance, inflammation, and non-alcoholic fatty liver disease Trends Endocrinol Metab 19 2008 371 379
30. E.M. Brunt, D.G. Tiniakos Histopathology of nonalcoholic fatty liver disease World J Gastroenterol 16 2010 5286 5296
31. A.D. Burt, A. Mutton, C.P. Day Diagnosis and interpretation of steatosis and steatohepatitis Semin Diagn Pathol 15 1998 246 258
32. S.G. Hübscher Histological assessment of non-alcoholic fatty liver disease Histopathology 49 2006 450 465
33. C. Lackner, M. Gogg-Kamerer, K. Zatloukal Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis J Hepatol 48 2008 821 828
34. A.E. Feldstein, G.J. Gores Apoptosis in alcoholic and nonalcoholic steatohepatitis Front Biosci 10 2005 3093 3099 http://DOI.org/10.2741/1765
35. E.M. Brunt Nonalcoholic steatohepatitis Semin Liver Dis 24 2004 3 20
36. S.H. Caldwell, R.H. Swerdlow, E.M. Khan Mitochondrial abnormalities in non-alcoholic steatohepatitis J Hepatol 31 1999 430 434
37. S.H. Caldwell, C.Y. Chang, R.K. Nakamoto, L. Krugner-Higby Mitochondria in nonalcoholic fatty liver disease Clin Liver Dis 8 2004 595 617
38. A. Alisi, G. Bedogni, R. De Vito Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease Dig Liver Dis 43 2011 143 146
39. M.M. Richardson, J.R. Jonsson, E.E. Powell Progressive fibrosis in nonalcoholic steatohepatitis: Association with altered regeneration and a ductular reaction Gastroenterology 133 2007 80 90
40. V. Nobili, M. Marcellini, R. Devito NAFLD in children: A prospective clinicalpathological study and effect of lifestyle advice Hepatology 44 2006 458 465
41. C. Carter-Kent, L.M. Yerian, E.M. Brunt Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study Hepatology 50 2009 1113 1120
42. Y. Takahashi, A. Inui, T. Fujisawa Histopathological characteristics of non-alcoholic fatty liver disease in children: Comparison with adult cases Hepatol Res 41 2011 1066 1074
43. D.E. Kleiner, E.M. Brunt, M. van Natta Design and validation of a histological scoring system for non-alcoholic fatty liver disease Hepatology 41 2005 1313 1321
44. E.M. Brunt, D.E. Kleiner, C. Behling Misuse of scoring systems Hepatology 54 2011 369 370
45. J.B. Schwimmer, R. Deutsch, J.B. Rauch Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease J Pediatr 143 2003 500 505
46. M. Rashid, E.A. Roberts Non-alcoholic steatohepatitis in children J Pediatr Gastroenterol Nutr 30 2000 48 53
47. K. Nanda Non-alcoholic steatohepatitis in children Pediatr Transplant 8 2004 613 618
48. A. Sobhonslidsuk, S. Jongjirasiri, A. Thakkinstian Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis World J Gastroenterol 13 2007 3614 3618
49. M.H. Fishbein, C. Mogren, T. Gleason, W.R. Stevens Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease J Pediatr Gastroenterol Nutr 42 2006 83 88
50. H.M. Patton, J.E. Lavine, M.L. Van Natta Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis Gastroenterology 135 2008 1961 1971 e2. DOI: 10.1053/j.gastro. 2008.08.050
51. M. Manco, A. Alisi, V. Nobili Risk of severe liver disease in NAFLD with normal ALT levels: A pediatric report Hepatology 48 2008 2087 2088
52. B. Canbakan, H. Senturk, M. Canbakan Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease? Biomark Med 4 2010 205 214
53. A.E. Feldstein, P. Charatcharoenwitthaya, S. Treeprasertsuk The natural history of nonalcoholic fatty liver disease in children: A follow-up study for up to 20 years Gut 58 2009 1538 1544
54. J.D. Yang, W.S. Harmsen, S.W. Slettedahl Factors that affect risk for hepatocellular carcinoma and effects of surveillance Clin Gastroenterol Hepatol 9 2011 617 623
55. B.Q. Starley, C.J. Calcagno, S.A. Harrison Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection Hepatology 51 2010 1820 1832
56. J. Ertle, A. Dechêne, J.P. Sowa Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis Int J Cancer 128 2011 2436 2443 10.1002/ijc.25797
57. S. Petta, A. Craxì Hepatocellular carcinoma and non-alcoholic fatty liver disease: From a clinical to a molecular association Curr Pharm Des 16 2010 741 752
58. A. Alisi, V. Nobili Metabolic syndrome and alcohol abuse: A potential hepatocarcinogenic mix in adolescents Clin Gastroenterol Hepatol 10 2011 204
59. L. Pacifico, C. Anania, F. Martino Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease Hepatology 52 2010 1643 1651
60. L.J. Benson, H.J. Baer, D.C. Kaelber Screening for obesity-related complications among obese children and adolescents: 1999-2008 Obes Silver Spring 19 2011 1077 1082
61. M.R. Riley, N.M. Bass, P. Rosenthal, R.B. Merriman Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists J Pediatr 147 2005 839 842
62. P. Mofrad, M.J. Contos, M. Haque Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values Hepatology 37 2003 1286 1292
63. J.D. Browning, L.S. Szczepaniak, R. Dobbins Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity Hepatology 40 2004 1387 1395
64. S.M. Mazhar, M. Shiehmorteza, C.B. Sirlin Noninvasive assessment of hepatic steatosis Clin Gastroenterol Hepatol 7 2009 135 140
65. E.S. Siegelman, M.A. Rosen Imaging of hepatic steatosis Semin Liv Dis 21 2001 71 80 10.1055/s-2001-12930
66. M. Chiloiro, G. Riezzo, S. Chiarappa Relationship among fatty liver, adipose tissue distribution and metabolic profile in moderately obese children: An ultrasonographic study Curr Pharm Des 14 2008 2693 2698
67. S. Dasarathy, J. Dasarathy, A. Khiyami Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study J Hepatol 51 2009 1061 1067
68. F. Springer, J. Machann, C.D. Claussen Liver fat content determined by magnetic resonance imaging and spectroscopy World J Gastroenterol 16 2010 1560 1566
69. S.H. Kim, J.M. Lee, J.K. Han Hepatic macrosteatosis: Predicting appropriateness of liver donation by using MR imaging Correlation with histopathologic findings Radiology 240 2006 116 129
70. M. Yoneda, K. Fujita, M. Inamori Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) Gut 56 2007 1330 1333
71. V. Nobili, F. Vizzutti, U. Arena Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis Hepatology 48 2008 442 448
72. M. Friedrich-Rust, M.F. Ong, S. Martens Performance of transient elastography for the staging of liver fibrosis: A meta-analysis Gastroenterology 134 2008 960 974
73. J.A. Talwalkar Elastography for detecting hepatic fibrosis: Options and considerations Gastroenterology 135 2008 299 302
74. B. Taouli, R.L. Ehman, S.B. Reeder Advanced MRI methods for assessment of chronic liver disease AJR Am J Roentgenol 193 2009 14 27
75. Y.K. Mariappan, K.J. Glaser, R.L. Ehman Magnetic resonance elastography: A review Clin Anat 23 2010 497 511
76. R.L. Ehman Science to practice: Can MR elastography be used to detect early steatohepatitis in fatty liver disease? Radiology 253 2009 1 3
77. J. Chen, J.A. Talwalkar, M. Yin Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography Radiology 259 2011 749 756
78. E. Fitzpatrick, R.R. Mitry, A. Quaglia Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD J Pediatr Gastroenterol Nutr 51 2010 500 506
79. I.N. Guha, J. Parkes, P. Roderick Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver fibrosis panel and exploring simple markers Hepatology 47 2008 455 460
80. V. Nobili, J. Parkers, G. Bottazzo Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease Gastroenterology 136 2009 160 167
81. V. Nobili, A. Alisi, G. Torre Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease Trans Res 156 2010 229 234 DOI:10.1016/j.trsl. 2010.05.008
82. V. Nobili, A. Alisi, A. Vania The pediatric NAFLD fibrosis index: A predictor of liver fibrosis in children with non-alcoholic fatty liver disease BMC Med 7 2009 21
83. L.A. Adams, A.E. Feldstein Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis J Dig Dis 12 2011 10 16
84. M.A. Huang, J.K. Greenson, C. Chao One-year intense nutritional counselling results in histological improvement in patients with non-alcoholic steatohepatitis: A pilot study Am J Gastroenterol 100 2005 1072 1081
85. E.A. Roberts, J. Yap Nonalcoholic fatty liver disease (NAFLD): Approach in the adolescent patient Curr Treat Options Gastroenterol 9 2006 423 431
86. M. Manco, M. Calvani, G. Mingrone Effects of dietary fatty acids on insulin sensitivity and secretion Diabetes Obes Metab 6 2004 402 413
87. M.F. Abdelmalek, A. Suzuki, C. Guy Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1961 1971
88. D.B. Jump, D. Botolin, Y. Wang Docosahexaenoic acid (DHA) and hepatic gene transcription Chem Phys Lipids 153 2008 3 13
89. V. Nobili, G. Bedogni, A. Alisi Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: Double-blind randomized controlled clinical trial Arch Dis Child 96 2011 350 353
90. V. Nobili, M. Manco, R. Devito Lifestyle intervention and antioxidant therapy in children with non-alcoholic fatty liver disease: A randomized, controlled trial Hepatology 48 2008 119 128
91. J.E. Lavine, J.B. Schwimmer, M.L. Van Natta Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial Jama 305 2011 1659 1668
92. V. Nobili, M. Manco, P. Ciampalini Metformin use in children with nonalcoholic fatty liver disease: An open-label, 24-month, observational pilot study Clin Ther 30 2008 1168 1176
93. P. Vajro, A. Franzese, G. Valerio Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children J Pediatr 136 2000 739 743
94. R. Orlando, L. Azzalini, S. Orando Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis Cochrane Database Syst Rev 1 2007 CD005160. DOI:10.1002/14651858.CD005160.pub2
95. A. Iacono, G.M. Raso, R. Berni Canani Probiotics as an emerging therapeutic strategy to treat NAFLD: Focus on molecular and biochemical mechanisms J Nutr Biochem 22 2011 699 711
96. S. Yokohama, M. Yoneda, M. Haneda Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis Hepatology 40 2004 1222 1225
97. H. Tilg, A. Moschen Update on nonalcoholic fatty liver disease: Genes involved in nonalcoholic fatty liver disease and associated inflammation Curr Opin Clin Nutr Metab Care 13 2010 391 396
98. M. Duvnjak, V. Tomasic, M. Gomercic Therapy of nonalcoholic fatty liver disease: Current status J Physiol Pharmacol 60 Suppl 7 2009 57 66
99. C. Buechler, J. Wanninger, M. Neumeier Adiponectin, a key adipokine in obesity related liver diseases World J Gastroenterol 17 2011 2801 2811
100. A. Mencin, J. Kluwe, R.F. Schwabe Toll-like receptors as targets in chronic liver diseases Gut 58 2009 704 720